KAULIV

This brand name is authorized in Austria, Estonia, Croatia, Ireland, Italy, Lithuania

Active ingredients

The drug KAULIV contains one active pharmaceutical ingredient (API):

1 Teriparatide UNII 10T9CSU89I - TERIPARATIDE

Teriparatide (rhPTH(1-34)) is the active fragment (1-34) of endogenous human parathyroid hormone. Teriparatide is a bone formation agent to treat osteoporosis. The skeletal effects of teriparatide depend upon the pattern of systemic exposure. Read about Teriparatide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
KAULIV Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H05AA02	Teriparatide	H Systemic hormonal preparations, excl. Sex hormones and insulins → H05 Calcium homeostasis → H05A Parathyroid hormones and analogues → H05AA Parathyroid hormones and analogues
Discover more medicines within H05AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 3038598, 3038600
Country: IT	Agenzia del Farmaco	Identifier(s): 050536010, 050536022
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1096681, 1096682